SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on January 8, 2024, reporting events occurring on January 5, 2024. The registrant is a Delaware corporation listed on The NASDAQ Capital Market under the symbol BSGM. The filing addresses a specific regulatory matter regarding the company's continued listing status.
Key Financial Metrics
The filing does not provide specific financial statements, revenue, profit, cash flow, or debt figures. The only quantitative metric disclosed is the Market Value of Listed Securities (MVLS), which reached or exceeded $35,000,000 for the required consecutive trading period.
Material Changes and Events
- Regulatory Compliance: The company previously received notice on December 19, 2023, of non-compliance with Nasdaq Listing Rule 5550(b)(2) due to an MVLS below $35,000,000 over a 30-day period.
- Resolution: On January 5, 2024, Nasdaq notified the company that it regained compliance. The MVLS closed at $35,000,000 or greater for 10 consecutive business days (December 20, 2023, to January 4, 2024).
- Status: The compliance matter is now closed, and the company is no longer under the 180-day compliance period that was set to expire on June 17, 2024.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of future risks beyond the resolution of the listing deficiency. No unusual items or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Verify the current trading volume and share price to ensure the MVLS remains above the $35,000,000 threshold to prevent future delisting notices.
- Confirm the company's stock symbol (BSGM) and exchange (NASDAQ Capital Market) status on the official Nasdaq website.
- Note that this filing resolves a specific listing deficiency but does not provide updated financial performance data.